Insulin Nation
OCTOBER 12, 2017
Integrated Diabetes Services (IDS) provides detailed advice and coaching on diabetes management from certified diabetes educators and dieticians. Insulin Nation and Type 2 Nation hosts a regular Q&A column from IDS that answers questions submitted from the diabetes community. Q – I’ve recently been diagnosed with diabetes and I’m scared of complications.
ACA Times
OCTOBER 12, 2017
States are taking more aggressive action to curb drug costs. It’s self-preservation. Prescription drug expenditures are nearly 20 percent of U.S. health care costs. According to the National Academy for State Health Policy , more than 30 states have either passed or are considering more than 60 bills designed to make drug pricing more transparent, to identify the costs that contribute to drug prices, and to make the business practices of pharmacy benefit managers (PBMs) easier to understand.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Insulin Nation
OCTOBER 12, 2017
Three or four years ago, a buzz started building that metformin could be a potential fountain of youth. In 2011, a group of researchers in oncology in St. Petersburg, Russia, found that metformin could prevent the advancement of cancer in mice, thereby increasing their lifespans. In 2012, several online health advocates passionately accused the FDA of sinister motivations for preventing the makers of metformin from advertising it as an anti-cancer and anti-vascular disease medicine.
Insulin Nation
OCTOBER 12, 2017
A new study by Medscape suggests that marijuana may be effective in treating pain caused by diabetic neuropathy. The study, published in the Journal of Pain , is reportedly the first to measure the effect of cannabis on diabetic neuropathy. It was led by researchers at the Division of Pain Management at the University of California, San Diego. The small study involved just 16 participants with either Type 1 or Type 2 diabetes and neuropathy.
Advertisement
Colington Consulting was established in 2013 and helps organizations achieve HIPAA compliance and ensures clients stay current with the latest enforcement trends. We provide a full range of HIPAA compliance services and consulting. What separates us from our competitors is our knowledge of HIPAA compliance regulations and their application to each of our client’s particular scenarios and requirements.
Insulin Nation
OCTOBER 12, 2017
Good news about metformin: it may help keep your brain healthy. The popular diabetes drug, which sensitizes the body to insulin and lowers glucose production in the liver, has been found to lower the risk of dementia in diabetes patients. A new Kaiser Permanente study found that the drug helped cut the risk of dementia by 20 percent. The study followed 15,000 Type 2 patients who were beginning to take one of four common diabetes drugs.
Connected Health Pulse brings together the best content for digital health professionals from the widest variety of industry thought leaders.
Insulin Nation
OCTOBER 12, 2017
The FDA recently warned that the diabetes drug canagliflozin has been linked to an increased risk of leg and foot amputation. Canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is used to help lower blood sugar levels in people with Type 2 diabetes. It’s marketed as a stand-alone drug therapy under the name of Invokana and as part of a combo therapy under the name of Invokamet.
Insulin Nation
OCTOBER 12, 2017
A new report suggests that prolonged use of metformin could lead to a vitamin B12 deficiency. This vitamin deficiency could cause peripheral neuropathy (nerve damage in the hands and feet) if not properly treated, according to the European Association for the Study of Diabetes. However, there are B12 supplements one can take to offset a deficiency, if properly diagnosed with the deficiency.
Insulin Nation
OCTOBER 12, 2017
A recent study suggests that metformin might be an effective treatment to heal against heart attacks for people with diabetes. This would be good news, as research shows that heart disease accounts for over half of all deaths for those with diabetes, and metformin is one of the most popular drugs prescribed to people with Type 2 diabetes. Researchers in the United Kingdom and Saudi Arabia used stem cells to simulate a heart attack in a lab.
Insulin Nation
OCTOBER 12, 2017
When calculating a person’s ability to control their diabetes, doctor’s measure their HbA1c (or A1C for short) score, which defines average blood sugar levels over a long period of time. The idea until recently has been that there is a standard range of A1C scores that every person with diabetes should shoot for, but many with the condition fall short of those numbers.
Advertisement
Effective collaboration among all care team members is critical to delivering better patient outcomes. A key element to achieving effective collaboration is through the implementation of a clinical communication and collaboration platform. In a fast-paced, high-stress and critical environment, people tend to do whatever gets the job done. Therefore will scramble and use the systems, people, or processes around them to get an outcome more quickly - which can often be at the expense of quality.
Insulin Nation
OCTOBER 12, 2017
When I first learned that I had Type 2 diabetes in 2001, I thought my world had come crumbling down right before my eyes. I’d been eating delicious things all my life and couldn’t bear the thought of having to do without. Having grown up in a household where diabetes runs in the family, all I could picture for the future was having to test my urine, take frequent naps, and dodge the complications that can arise from the disease.
Insulin Nation
OCTOBER 12, 2017
If you have diabetes, don’t be surprised if your doctor prescribes statins in 2014. In what has been described as a potentially-seismic shift in health policy, the American Heart Association and several other medical groups have changed the guidelines for the use of statins, a group of popular cholesterol-lowering drugs. According to the new guidelines, doctors should no longer wait for a patient’s LDL (bad) cholesterol level to reach above 130 milligrams per deciliter to begin prescribing stat
Insulin Nation
OCTOBER 12, 2017
In 2015, the American College of Radiology (ACR) changed their guidelines for how radiologists should handle patients using metformin. Metformin is an oral drug which lowers blood sugar levels by decreasing the amount of sugar produced in the liver and increasing the sensitivity of muscle cells to insulin. Metformin is then eliminated by the kidneys.
Insulin Nation
OCTOBER 12, 2017
Thiazolidinediones (TZDs) are a commonly-used therapy for the treatment of insulin resistance in Type 2 diabetes. TZDs are often used in combination with sulfonylureas , metformin, or both. They act to reduce insulin resistance by producing more fat cells. The cells produced are more sensitive to insulin and have a higher chance of being used to process glucose.
Advertisement
Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, introduces HeartKit, its latest addition to neuralSPOT. This optimized AI model enables running various real-time heart monitoring applications to help users and their healthcare providers quickly identify any irregular events to take necessary actions.
Insulin Nation
OCTOBER 12, 2017
Know Your Drugs. A drug prescription can come with a lot of questions. With our “Know Your Drugs” series, we provide you with a snapshot of the different diabetes drugs on the market, and links to additional information. Metformin may be the most widely prescribed drug for Type 2 diabetes, but a lesser-known type of drug, sulfonylureas (SUs), ranks second.
Insulin Nation
OCTOBER 12, 2017
Several lawsuits allege a class of oral diabetes drugs called SGLT2 inhibitors cause cardiovascular and urinary tract complications and brittle bones. Personal injury law firms have brought suits on behalf of residents in Florida, Alabama, Texas, California, Tennessee, and Louisiana, and a claim filed in Canada is reportedly awaiting class action certification.
Insulin Nation
OCTOBER 12, 2017
Medscape recently reported on a review of over 200 studies that measured the effectiveness of blood sugar-lowering drugs. A review like this hasn’t been carried out since 2011, and since then many new drugs have hit the market. Here are some key findings: Blood sugar-lowering effects. While many of the diabetes drugs reviewed lowered A1C scores, two (metformin and sulfonylureas) seemed to lower blood sugar levels the most.
Insulin Nation
OCTOBER 12, 2017
One common complication of Type 2 diabetes is that high blood sugar levels can make the kidneys work too hard. Unfortunately, many medications to lower blood sugar levels are not considered safe for people with kidney problems. Use of metformin, for example, has been restricted for those with kidney issues because the drug is removed from the body via the kidneys, and it can build up in those with lower kidney function.
Advertisement
This report explores current issues in the behavioral health industry in 2023. Topics covered include quantitative statistics describing the overall increase in behavioral health issues, the impact of psychologist and staff burnout, how HIPAA compliance is once again at the top of our minds & much more!
Insulin Nation
OCTOBER 12, 2017
A combo treatment of metformin and canagliflozin was more effective for blood sugar control than either of the drugs individually, according to a recent study conducted by the research arm of drugmaker Janssen Pharmaceuticals. The Phase III study tracked 1,186 people with Type 2 diabetes across 12 countries and 158 medical centers for 26 weeks; none of the group had started diabetes drug therapy prior to the study.
Insulin Nation
OCTOBER 12, 2017
As Type 2 diabetes progresses, some people with the condition must supplement their body’s natural insulin production with drug therapy. This can include taking GLP-1 drugs, a relatively new drug therapy which encourages the body’s natural insulin production and lessens the body’s insulin needs. One drawback to GLP-1 drugs is that they often must be injected semi-regularly, adding to the weekly fingerpricks and injections many with diabetes already must endure.
Insulin Nation
OCTOBER 12, 2017
A U.S. Food and Drug Administration advisory board recommended updated warning labels for heart patients taking the diabetes oral medications Saxagliptin and Alogliptin, according to a Medscape Medical News report. The decision is based upon studies presented in the New England Journal of Medicine which presented data suggesting that it was difficult to rule out increased risk of heart failure with these drugs.
Insulin Nation
OCTOBER 12, 2017
Has your doctor mentioned something called SGLT2 inhibitors? The acronym may sound like a mouthful, but the full name is even wordier: Sodium-glucose co-transporter-2 inhibitors. Whatever you call them, this class of drugs is the latest line of defense in prescribed medication for the treatment of Type 2 diabetes. The drugs work by blocking SGLT2 proteins in the kidneys, which lowers the amount of blood sugar absorbed into the bloodstream.
Speaker: Dr. Mauvareen Beverley, Patient Engagement and Cultural Competence Specialist
If you’re a healthcare provider, chances are you have experienced symptoms of burnout yourself or have colleagues who are currently facing extreme career dissatisfaction. One of the many ways to partially alleviate burnout is active patient engagement. By engaging with patients to understand their needs and preferences, healthcare providers can develop treatments tailored to the individual patient.
Insulin Nation
OCTOBER 12, 2017
Metformin may be one of the most widely used drugs in the 21st century. Now, a new study seems to indicate it’s also one of the most misunderstood. Since metformin hit the UK market more than half a century ago, clinicians have worked under the premise that the drug works primarily in the bloodstream. Metformin is considered a wonder drug for its ability to suppress glucose production in the liver and increase insulin sensitivity in tissue, but how the drug does this has been debated for years.
Insulin Nation
OCTOBER 12, 2017
When it comes to blood sugar control, knowledge is power. People with diabetes who are vigilant about monitoring their blood sugar levels can identify patterns throughout the day and make corrections. To do this, some people with diabetes use a device called a continuous glucose monitor, which automatically monitors blood sugar readings every few minutes.
Expert insights. Personalized for you.
42 
Let's personalize your content